Aveanna Healthcare Holdings Inc. (AVAH) vs Enliven Therapeutics, Inc. (ELVN)

A side-by-side comparison of Aveanna Healthcare Holdings Inc. and Enliven Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVAH vs ELVN

growth of $100 · dividends reinvested · last 5y
AVAH +3.1% (+0.6%/yr)ELVN +46.7% (+8.0%/yr)ELVN compounded faster over this window
050100150200Start $10020222023202420252026$103$147
AVAH ELVN

AVAH vs ELVN: by the numbers

  • •ELVN is the larger company ($3.03B vs $2.66B market cap).
  • •AVAH is profitable (10.56% net margin) while ELVN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVAHELVN
P/E ratio9.67N/A
Forward P/E14.84N/A
P/S ratio1.02N/A
P/B ratio9.263.38
EV / EBITDA13.13N/A
FCF yield5.95%N/A

Profitability

MetricAVAHELVN
Gross margin31.95%0.00%
Operating margin11.12%0.00%
Net margin10.56%0.00%
ROE95.64%-11.83%
ROIC15.45%-13.88%

Growth (annualized)

MetricAVAHELVN
Revenue CAGR (5Y)9.65%N/A
FCF CAGR (5Y)58.99%N/A
Total return CAGR (5Y)9.75%24.57%

Frequently asked

Is AVAH or ELVN more profitable?
AVAH runs the higher net margin — AVAH at 10.56% versus ELVN at 0.00%.
How have AVAH and ELVN total returns compared?
Over the past 5 years, AVAH delivered 9.75% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.